EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer

Shuqing Wang, Zhiying Mao, Yuying Liu, Chunyan Lan, Lizhi Liu, Musheng Zeng, Chuanbo Xie

Cellular Oncology · 2025

DOI: 10.1007/s13402-025-01092-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2025. Verfasst von Shuqing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen Univ…. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Guangdong Province of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Apo10 and TKTL1 are tumor-associated markers reflecting impaired apoptosis and enhanced glycolysis respectively. This study aimed to evaluate the diagnostic potential of Apo10, TKTL1, and APT (a combination of Apo10 and TKTL1) in screening early-stage cervical cancer.

Methods

A total of 152 patients with cervical cancer and 152 age-matched healthy controls were enrolled at Sun Yat-sen University Cancer Center from November 2020 to August 2023. Clinical data were collected from the Hospital Information System (HIS) and medical records, and blood samples were collected from all participants before treatment using epitope detection in monocytes (EDIM) technology 60 min after their last meal. Descriptive statistics and receiver operating characteristic (ROC) curves were used to compare the diagnostic performance of Apo10, TKTL1, and APT to those of conventional cervical cancer biomarkers (CEA, CA125, and SCC-A).

Results

Most of the enrolled patients with cervical cancer had early-stage disease (70%) and squamous cell histology (84.9%). The Apo10, TKTL1, and APT levels were significantly higher in the cervical cancer group than in the control group (Apo10:139 vs. 132, TKTL1:121 vs. 114, APT: 260 vs. 246). We also found that Apo10, TKTL1, and APT showed superior diagnostic performance (AUC: 0.864, 0.865, 0.905) compared to traditional markers (CEA: 0.690, CA125: 0.594, SCC-A: 0.806). Sensitivity analysis revealed APT maintained high diagnostic value across tumor stages and in both HPV-negative (AUC = 0.967) and TCT-negative (AUC = 0.958) subgroups.

Conclusion

Apo10, TKTL1, and APT outperform conventional biomarkers in detecting cervical cancer and may serve as reliable diagnostic indicators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsBiomarkers, TumorEarly Detection of CancerMacrophagesTransketolaseHumansFemaleMiddle AgedAdultCase-Control StudiesROC CurveAgedSerum Albumin, HumanCarrier ProteinsGlycoproteins

Stichwörter der Autor:innen

Apo10Cervical cancerScreeningTKTL1

Substanzen

Biomarkers, TumorTKTL1 protein, humanTransketolaseAFM protein, humanSerum Albumin, HumanCarrier ProteinsGlycoproteins

Autor:innen und Institutionen

  • Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.
  • Department of Gynecologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China.…
  • Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Guangzhou, Guangdong, 510060, China. zengmsh@sysucc.org.cn.
  • Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China. xiechb@sysu…

Förderung

  • Medical Scientific Research Foundation of Guangdong Province of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Wang, S., Mao, Z., Liu, Y., Lan, C., Liu, L., Zeng, M., & Xie, C. (2025). Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer. Cellular Oncology. https://doi.org/10.1007/s13402-025-01092-3

Vancouver

Wang S, Mao Z, Liu Y, Lan C, Liu L, Zeng M, et al. Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer. Cellular Oncology. 2025. doi:10.1007/s13402-025-01092-3

BibTeX
@article{Wang2025,
  author = {Wang, Shuqing and Mao, Zhiying and Liu, Yuying and Lan, Chunyan and Liu, Lizhi and Zeng, Musheng and Xie, Chuanbo},
  title = {Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancer},
  journal = {Cellular Oncology},
  year = {2025},
  doi = {10.1007/s13402-025-01092-3}
}
Kostenlos starten →